Isologic Innovative Radiopharmaceuticals (ISOLOGIC)
David Paradis, CPA, CFA has a diverse work experience spanning over 25 years. David Paradis has worked in various roles, including Vice President Finance at Isologic Innovative Radiopharmaceuticals, where they played a vital role in supplying radiopharmaceuticals to hospitals and clinics across Canada. Prior to that, they worked as a Finance Lead/Consultant at their own company, David Paradis, where they provided financial consulting services to various organizations, including enGene Inc. During this time, they assisted with ERP implementation, financial statement transformation, and other ad-hoc interventions.
David also served as the Vice President Finance at Brault et Bouthillier, a distributor/retailer of teaching material and educational supplies in Canada. Here, they successfully debugged and redeployed the legacy ERP system, introduced new management systems and business processes, and established quality relationships in a high-pressure banking situation.
Other notable experiences include working as a Consultant at AGCO Corporation, where they set up a reporting infrastructure to meet the parent company's requirements, and serving as the Corporate Controller at Sanimax, where they oversaw a large accounting team and implemented an accounting consolidation platform.
David started their career at KPMG, where they worked for over 9 years and held the position of Senior Manager- Transaction Advisory, with a focus on technology. David Paradis managed file delivery and execution, trained and directed junior staff, and successfully completed private equity financings, mergers and acquisitions, business turnarounds, and business valuations.
Overall, David Paradis has a strong background in finance and accounting, with expertise in financial management, strategic planning, process optimization, and financial controls.
David Paradis CPA, CFA completed Level 3 at the CFA Institute. David Paradis also holds a Bachelor of Business Administration (B.B.A.) degree in Finance and Accounting from Université Laval.
This person is not in any offices
Isologic Innovative Radiopharmaceuticals (ISOLOGIC)
1 followers
Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian radiopharmaceutical company (nuclear pharmacy), dedicated to nuclear medicine and the science of Radiopharmaceutical production. Our commitment to these fields extends to the communities we serve. We utilize our significant experience, expertise and networks in Nuclear Pharmacy to provide our customers and patients with reliable; safe and high quality radiopharmaceutical products and services. ISOLOGIC’s network of SPECT & PET Radiopharmacies, positions us to service Group Purchase Organizations; regional health care systems, as well as stand-alone Independant Healthcare Facilities; clinics and hospitals. Our open formulary of Radiopharmaceutical drugs and medical devices, provides the flexibility of choice, providing our customers access to all radiopharmaceuticals, having Health Canada market authorization. En français : Isologic Innovative Radiopharmaceuticals (ISOLOGIC) est une entreprise radiopharmaceutique canadienne (pharmacie nucléaire), dédiée à la médecine nucléaire et à la science de la production radiopharmaceutique. Notre engagement dans ces domaines s'étend aux communautés que nous servons. Nous utilisons notre expérience, notre expertise et nos réseaux en pharmacie nucléaire pour fournir à nos clients et patients des produits et services radiopharmaceutiques fiables, sûrs et de haute qualité. Le réseau de radiopharmacies SPECT et PET d'ISOLOGIC nous permet de servir les organisations d'achats groupés, les systèmes de santé régionaux, ainsi que les établissements de santé indépendants, les cliniques et les hôpitaux. Notre formulaire ouvert de médicaments radiopharmaceutiques et de dispositifs médicaux offre la flexibilité du choix, en fournissant à nos clients l'accès à tous les produits radiopharmaceutiques, ayant une autorisation de mise sur le marché de Santé Canada.